Bay e r R e t u r n s a $332 Mi ll ion V e rdict i n a R o u n dup Tria l

OxyContin Update:

The Supreme Court has heard arguments challenging the bankruptcy deal aimed at compensating victims of the highly addictive painkiller OxyContin, manufactured by Purdue Pharma.

The deal, protecting the Sackler family from personal liability, faced objections from the United States Trustee and the Biden administration, arguing that bankruptcy law shouldn't allow such liability releases.

The Centers for Disease Control and Prevention Announce a Listeria Outbreak

Ozempic is being tested on children with obesity as young as six years old. However, there are concerns about the potential harm caused by these drugs, with lawsuits filed after reports of gastrointestinal issues from the off-label weight loss drug. Both Mounjaro and Ozempic have surged in popularity as diabetes and obesity treatments, but adverse effects have led to warnings and legal actions.

If you or a loved one have faced adverse health effects from Ozempic or Mounjaro, call Moll Law Group at 312.462.1700 or complete our form at molllawgroup.com.

FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines

The FDA has issued a warning about a rare but serious drug reaction associated with certain antiseizure medications, specifically Levetiracetam and Clobazam. These medications are generically known as Keppra, Keppra XR, Elepsia XR, Spritam, Onfi or Sympazan.

Patients are advised to seek medical attention if they experience symptoms such as swollen lymph nodes, fever, or unexplained rash

Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump

The Novum IQ syringe infusion pump has been reported to incorrectly display “Infusion Complete” which may lead to underdosing or interruption of therapy, posing potential health risks. The pump is produced by Baxter International and has been issued for an Urgent Medical Device Correction.

If you or a loved one has suffered an injury or complication from the Novum IQ syringe infusion pump, contact Moll Law Group at 312.462.1700 or complete our form at molllawgroup.com.

Bayer Returns a $332 Million Verdict in a Roundup Trial

The Centers for Disease Control and Prevention Announce a Listeria Outbreak

FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines

Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump

Bay e r R e t u r n s a $332 Mi ll ion V e rdict i n a R o u n dup Tria l